Press releases
- Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes
- Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
- Dexcom Announces Upcoming Conference Presentation
- Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
More ▼
Key statistics
As of last trade DEXCOM INC DRN (D1EX34:SAO) traded at 12.27, -15.09% below its 52-week high of 14.45, set on Apr 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.31 |
---|---|
High | 12.31 |
Low | 12.27 |
Bid | 12.17 |
Offer | 12.23 |
Previous close | 13.20 |
Average volume | 13.50 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 04 2024 16:25 BST.
More ▼